In March 2022, Evusheld was authorised for use in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA). This treatment is aimed at adults who are unlikely to mount an immune response from COVID-19 vaccination or for whom vaccination is not recommended Procurement of this drug has stalled and myaware has been involved in asking for clarification as to why this drug isn’t yet available. 

For updates please see our website